Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RICHARD A MANCH

Allopathic & Osteopathic Physicians Internal Medicine Hepatology

NPI
1043289341
CMS profile
318885
Location
GLENDALE, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$125,774.89

180 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Gilead Sciences, Inc. $58,657.13 61
Madrigal Pharmaceuticals $34,079.42 44
ABBVIE INC. $11,822.18 24
Ipsen Biopharmaceuticals, Inc $10,777.08 20
Intercept Pharmaceuticals, Inc. $9,918.88 19
Novo Nordisk Inc $193.07 4
Sirtex Medical Inc $162.67 1
AstraZeneca Pharmaceuticals LP $62.33 2
Intra-Sana Laboratories $46.31 2
ORPHALAN INC $40.05 2
Eton Pharmaceuticals, Inc. $15.77 1

Page 2 of 4; records 51–100 of 180 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RICHARD A MANCH

NPI 1043289341 · CMS profile ID 318885

Allopathic & Osteopathic Physicians / Internal Medicine / Hepatology

GLENDALE, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 180 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1043289341?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RICHARD A MANCH, NPI 1043289341, CMS profile ID 318885. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 180 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1043289341?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). RICHARD A MANCH, NPI 1043289341, CMS profile ID 318885. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 180 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1043289341?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
RICHARD A MANCH, NPI 1043289341, CMS profile ID 318885, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 180 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1043289341?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

180 matching records · $125,774.89 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 180 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 180.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Gilead Sciences, Inc. $206.0708/26/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234369844 CMS
Gilead Sciences, Inc. $135.0008/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234378622 CMS
Gilead Sciences, Inc. $27.1608/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234457376 CMS
Ipsen Biopharmaceuticals, Inc $19.9008/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208855239 CMS
Gilead Sciences, Inc. $32.9008/15/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234373441 CMS
Madrigal Pharmaceuticals $150.0008/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248285224 CMS
Madrigal Pharmaceuticals $4,935.0008/14/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1248285226 CMS
Madrigal Pharmaceuticals $203.0008/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1248285228 CMS
Madrigal Pharmaceuticals $177.1008/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1248285230 CMS
Madrigal Pharmaceuticals $7.2708/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248285222 CMS
Gilead Sciences, Inc. $25.5508/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234469749 CMS
Gilead Sciences, Inc. $3.4908/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234606635 CMS
AstraZeneca Pharmaceuticals LP $27.9408/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206651536 CMS
ABBVIE INC. $4,600.0007/30/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1203007983 CMS
Gilead Sciences, Inc. $21.6307/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234509223 CMS
Madrigal Pharmaceuticals $70.4407/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248285214 CMS
Madrigal Pharmaceuticals $38.0307/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248285216 CMS
Madrigal Pharmaceuticals $94.6507/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248285218 CMS
Madrigal Pharmaceuticals $57.4107/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248285220 CMS
Madrigal Pharmaceuticals $24.8807/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248285198 CMS
Madrigal Pharmaceuticals $66.0007/18/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1248285200 CMS
Madrigal Pharmaceuticals $23.8007/18/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1248285202 CMS
Madrigal Pharmaceuticals $388.9607/18/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1248285204 CMS
Madrigal Pharmaceuticals $244.0807/18/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1248285206 CMS
Madrigal Pharmaceuticals $124.0807/18/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1248285208 CMS
Madrigal Pharmaceuticals $196.1407/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248285210 CMS
Madrigal Pharmaceuticals $5,287.5007/18/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1248285212 CMS
ABBVIE INC. $13.0307/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203007981 CMS
Gilead Sciences, Inc. $3,790.0007/15/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1234354633 CMS
Gilead Sciences, Inc. $3,790.0007/15/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1234354635 CMS
ABBVIE INC. $25.0007/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203007967 CMS
ABBVIE INC. $40.0007/11/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1203007969 CMS
ABBVIE INC. $290.9107/11/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1203007971 CMS
ABBVIE INC. $346.0907/11/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1203007973 CMS
ABBVIE INC. $60.0007/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203007975 CMS
ABBVIE INC. $25.0007/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203007977 CMS
ABBVIE INC. $70.0007/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203007979 CMS
Gilead Sciences, Inc. $31.7107/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234429414 CMS
Ipsen Biopharmaceuticals, Inc $30.9807/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208855237 CMS
Gilead Sciences, Inc. $21.0007/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234374059 CMS
Gilead Sciences, Inc. $25.5106/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234470053 CMS
Intercept Pharmaceuticals, Inc. $71.6406/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249876296 CMS
Madrigal Pharmaceuticals $39.6906/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248285196 CMS
Intercept Pharmaceuticals, Inc. $3,240.0006/19/2025 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: NEW
06/30/2026 1249876300 CMS
Intercept Pharmaceuticals, Inc. $125.0006/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249876302 CMS
Gilead Sciences, Inc. $9.5506/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234587746 CMS
Madrigal Pharmaceuticals $33.8506/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248285194 CMS
ABBVIE INC. $12.7606/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203007965 CMS
Gilead Sciences, Inc. $3,790.0006/06/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1234354631 CMS
Gilead Sciences, Inc. $33.6006/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234373399 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $120,121.05 188
PY2020 $26,946.22 55
PY2021 $33,214.38 80
PY2022 $93,170.95 126
PY2023 $62,331.63 104
PY2024 $72,802.09 111
PY2025 $125,774.89 180

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $16,135.74 24
PY2024 Principal investigator $80,822.63 47
PY2023 Principal investigator $132,769.92 29
PY2022 Principal investigator $47,062.01 18
PY2021 Principal investigator $58,279.52 19
PY2020 Principal investigator $127,319.53 40
PY2019 Recipient $1,166.55 9
PY2019 Principal investigator $215,949.28 31

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

24 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Eli Lilly and Company $1,395.66 12/17/2025 Non-covered Recipient Entity
INSTITUTE FOR LIVER HEALTH LLC
A MASTER PROTOCOL FOR A RANDOMIZED, CONTROLLED, CLINICAL TRIAL OF MULTIPLE PHARMACOLOGIC AGENTS IN ADULT PARTICIPANTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE WHO ARE AT INCREASED RISK OF DEVELOPING MAJOR ADVERSE LIVER OUTCOMES No dispute reported 06/30/2026 1187883858
Principal investigator 1 Eli Lilly and Company $915.38 12/17/2025 Non-covered Recipient Entity
INSTITUTE FOR LIVER HEALTH LLC
A MASTER PROTOCOL FOR A RANDOMIZED, CONTROLLED, CLINICAL TRIAL OF MULTIPLE PHARMACOLOGIC AGENTS IN ADULT PARTICIPANTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE WHO ARE AT INCREASED RISK OF DEVELOPING MAJOR ADVERSE LIVER OUTCOMES No dispute reported 06/30/2026 1187884010
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $2,000.00 07/10/2025 Non-covered Recipient Entity
THE INSTITUTE FOR LIVER HEALTH II LLC
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of siRNA Gene Silencing for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Participants With Genetic Risk Factors No dispute reported 06/30/2026 1184214226
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $750.00 07/10/2025 Non-covered Recipient Entity
THE INSTITUTE FOR LIVER HEALTH II LLC
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of siRNA Gene Silencing for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Participants With Genetic Risk Factors No dispute reported 06/30/2026 1184214656
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $2,625.00 07/10/2025 Non-covered Recipient Entity
THE INSTITUTE FOR LIVER HEALTH II LLC
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of siRNA Gene Silencing for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Participants With Genetic Risk Factors No dispute reported 06/30/2026 1184214658
Principal investigator 1 Boehringer Ingelheim International GmbH $33.71 03/27/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trial (MASH F4) No dispute reported 06/30/2026 1220748838
Principal investigator 1 Boehringer Ingelheim International GmbH $2.14 03/27/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trial (MASH F4) No dispute reported 06/30/2026 1220748840
Principal investigator 1 Boehringer Ingelheim International GmbH $12.86 03/27/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trial (MASH F4) No dispute reported 06/30/2026 1220748842
Principal investigator 1 Boehringer Ingelheim International GmbH $259.00 03/27/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trial (MASH F4) No dispute reported 06/30/2026 1220748844
Principal investigator 1 Boehringer Ingelheim International GmbH $5.52 03/27/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trial (MASH F4) No dispute reported 06/30/2026 1220748846
Principal investigator 1 Boehringer Ingelheim International GmbH $1.50 03/27/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trial (MASH F4) No dispute reported 06/30/2026 1220748848
Principal investigator 1 Boehringer Ingelheim International GmbH $1.50 03/27/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trial (MASH F4) No dispute reported 06/30/2026 1220748850
Principal investigator 1 Boehringer Ingelheim International GmbH $21.43 03/27/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trial (MASH F4) No dispute reported 06/30/2026 1220748852
Principal investigator 1 Boehringer Ingelheim International GmbH $151.58 03/25/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trial (MASH F4) No dispute reported 06/30/2026 1220748854
Principal investigator 1 Boehringer Ingelheim International GmbH $139.86 03/25/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trial (MASH F4) No dispute reported 06/30/2026 1220748856
Principal investigator 1 Boehringer Ingelheim International GmbH $620.50 03/25/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trial (MASH F4) No dispute reported 06/30/2026 1220748858
Principal investigator 1 Boehringer Ingelheim International GmbH $39.08 03/25/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trial (MASH F4) No dispute reported 06/30/2026 1220748860
Principal investigator 1 Boehringer Ingelheim International GmbH $5.00 03/25/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trial (MASH F4) No dispute reported 06/30/2026 1220748862
Principal investigator 1 Boehringer Ingelheim International GmbH $151.58 03/25/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trials No dispute reported 06/30/2026 1220748864
Principal investigator 1 Boehringer Ingelheim International GmbH $139.86 03/25/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trials No dispute reported 06/30/2026 1220748866
Principal investigator 1 Boehringer Ingelheim International GmbH $620.50 03/25/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trials No dispute reported 06/30/2026 1220748868
Principal investigator 1 Boehringer Ingelheim International GmbH $39.08 03/25/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trials No dispute reported 06/30/2026 1220748870
Principal investigator 1 Boehringer Ingelheim International GmbH $5.00 03/25/2025 Non-covered Recipient Entity
Arizona Liver Health Flagstaff Liver Clinic
-Ph III MASH pivotal trials No dispute reported 06/30/2026 1220748872
Principal investigator 1 AstraZeneca Pharmaceuticals LP $6,200.00 02/21/2025 Non-covered Recipient Entity
ARIZONA LIVER HEALTH
A Randomised, Double-blind, Placebo-controlled, Multi-centre Phase 2b Study to Evaluate the Efficacy, Safety and Tolerability of AZD2693 in Participants with Non-cirrhotic Non-alcoholic Steatohepatitis (NASH) with Fibrosis Who Are Carriers of the PNPLA3 rs738409 148M Risk Allele No dispute reported 06/30/2026 1185545907